. Author manuscript; available in PMC: 2014 Apr 10.

Published in final edited form as: Hum Hered. 2013 Apr 10;75(1):10.1159/000346195. doi: 10.1159/000346195

Table 1.

Characteristics of study population

	NAFLD +	NAFLD −	p-value^*
N	748	344
Female, N (%)	579 (77.4%)	296.0 (86.0%)	0.001
Age, years (mean ± SD)	47 ± 10.6	46 ± 11.8	0.36
BMI, kg/m² (mean ± SD)	50.4 ± 8.9	49.6 ± 8.6	0.22
Waist Circumference, in (mean ± SD)	54.2 ± 6.7	52.4 ± 6.2	<0.0001
Diabetes, N (%)	292 (39%)	93 (27%)	0.0007
Total cholesterol, mg/dl (mean ± SD)	191.7 ± 40.8	185.4 ± 40.8	0.006
HDL-cholesterol, mg/dl (mean ± SD)	46.3 ± 10.6	50.9 ± 12.1	<0.0001
LDL-cholesterol, mg/dl (mean ± SD)	107.6 ± 34.5	106.4 ± 36.0	0.39
Triglycerides, mg/dl (mean ± SD)	197.4 ± 141.2	140.3 ± 69.4	<0.0001
Statin Therapy, N (%)	228 (30%)	117 (34%)	0.07
Fibrate Therapy, N (%)	41 (5%)	20 (6%)	0.38
Statin or Fibrate Therapy, N (%)	250 (33%)	122 (35%)	0.14

BMI, Body mass index; NAFLD, Non-alcoholic fatty liver disease

Adjusted for age and sex (sex is only adjusted for age and age only adjusted for sex)

NAFLD was graded using the criteria of Brunt [12]. NAFLD − = grade 0; NAFLD + = grade ≥1.